Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • How big is the problem?
    • How we drive change
    • Our story
  • Featured insights
    • The latest at the Foundation
    • The latest at the Foundation
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • Become a catalyst
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
  • Achievements so far
    • The Foundation's impact
    • The Foundation's impact
  • News
  • Our team
  • Our impact
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us
Photo of: Martijn van Gerven
Researcher

Martijn van Gerven

Martijn van Gerven is a Researcher for the Antimicrobial Resistance Benchmark. He holds a BSc and MSc in Nutrition and Health from Wageningen University & Research and focused on translating fundamental science into accessible innovations. He completed a minor in Immunology and Genetics at Stockholm University. In addition, he earned a degree for the completion of the MSc Track Entrepreneurship. Martijn also completed an internship at a Life Science consultancy where he researched and assisted Dutch biotech companies on their needs for business development support.

Before joining the Foundation, Martijn worked as a consultant with pharmaceutical companies to kickstart projects that enhance affordable, value-based and patient-centred healthcare.

The Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Copyright 2004 - 2022 Access to Medicine Foundation - All Rights Reserved